Related Experiment Video

Updated: Apr 17, 2026

Oligopeptide Competition Assay for Phosphorylation Site Determination
09:16

Oligopeptide Competition Assay for Phosphorylation Site Determination

Published on: May 18, 2017

9.0K

The activity of cAMP-phosphodiesterase 4D7 (PDE4D7) is regulated by protein kinase A-dependent phosphorylation within

Ashleigh M Byrne1, Christina Elliott1, Ralf Hoffmann2

  • 1Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.

FEBS Letters
|February 15, 2015
PubMed

Insights

Researchers discovered a new regulatory mechanism for cyclic AMP phosphodiesterases type 4 (PDE4s). This finding reveals how PDE4D7 activity is controlled, impacting cellular signaling in conditions like prostate cancer and ischemic stroke.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • Cyclic AMP phosphodiesterases type 4 (PDE4s) regulate intracellular cyclic AMP (cAMP) levels.
  • PDE4 isoforms exhibit cell-specific expression and targeting via N-terminal domains.
  • Long form PDE4s are activated by PKA phosphorylation in the UCR1 region.

Purpose of the Study:

  • To identify and characterize a novel protein kinase A (PKA) phosphorylation site in the N-terminal region of PDE4D7.
  • To investigate the functional consequences of this novel phosphorylation on PDE4D7 activity and cAMP signaling.

Main Methods:

  • Site-directed mutagenesis to investigate phosphorylation.
  • Enzyme activity assays to measure PDE4 activity.
  • Analysis of cAMP levels under basal and stimulated conditions.

Main Results:

  • A novel PKA phosphorylation site (serine 42) was identified in the N-terminus of PDE4D7.
  • Phosphorylation at this N-terminal site constitutively inhibits PDE4D7 activity.
  • This inhibition allows for sustained cAMP signaling under basal conditions, contrasting with UCR1-mediated activation.

Conclusions:

  • The N-terminal PKA site on PDE4D7 represents a novel regulatory mechanism for PDE4 activity.
  • This regulatory site plays a role in controlling cAMP signaling, potentially impacting cellular processes in prostate cancer and ischemic stroke.
Keywords:
Cyclic-AMPPDE4D7PKAPeptide arrayProstate cancer

More Related Videos

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

887
Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

7.1K

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.4K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.7K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.7K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K